Clinical presentation of parvovirus B19 infection in HIV-infected patients with and without AIDS

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 36, Issue 2, 2003, Pages 299-302

  Setúbal, Sérgio ^a,c   Jorge Pereira, Maria Cristina ^b   Martins de Sant'Anna, Anadayr Leite ^b   Artimos ee Oliveira, Solange ^a   Bazin, Anna Ricordi ^c   Pereira do Nascimento, Jussara ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b State Inst Hematol Arthur de S   (Brazil)

^c NONE

Author keywords

AIDS; Erythema infectiosum; Parvovirus; Pure red cell aplasia; Sickle cell anemia

Indexed keywords

COTRIMOXAZOLE; DIDANOSINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISONE; VIRUS DNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROCYTE APLASIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PARVOVIRUS; RASH; VIRUS INFECTION; VIRUS LOAD;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HYDROPS; PARVOVIRUS;

EID: 0038198871     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822003000200014     Document Type: Article

References (12)

1. Aguiar FS, Lopes DP, Bazin AR, Setúbal S, Cohen BJ, Nascimento JP. Human parvovirus B19 infection in HIV-positive patients. Revista da Sociedade Brasileira de Medicina Tropical 34: 239-242, 2001.
2. Borkowski J, Amrikachi M, Hudnall SD. Fulminant parvovirus infection following erythropoietin treatment in a patient with acquired immunodeficiency syndrome. Archives of Pathology & Laboratory Medicine 124: 441-445, 2000.
3. Brown KE, Young NS. Human Parvovirus B19: Pathogenesis: of Disease. In: Anderson LJ, Young NS (eds) Human Parvovirus B19. Monographs in Virology, Basel, Karger, volume 20, 1997.
4. Frickhoten N, Abkowitz JL, Safford M, Berry JM, Antunez-de-Mayolo J, Astrow A, Cohen R, Halperin I, King L, Mintzer D, Cohen B, Young NS. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Annals of Internal Medicine 113:926-933, 1990.
5. Goedert JJ, Erdman DD, Konkle BA, Török TJ, Lederman MM, Kleinert D, Mandalaki T, Kessler CM, Anderson LJ, Luban NLC. Parvovirus B19 quiescence during the course of Human Immunodeficiency Virus Infection in persons with hemophilia. American Journal of Hematololgy 56: 248-251, 1997.
6. Koduri PR. Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection. American Journal of Hematology 58: 95-99, 1998.
7. Koduri PR, Kumapley R, Valladares J, Teter C. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin, a report of eight patients. American Journal of Hematology 61: 16-20, 1999.
8. Morí J, Field AJ, Clewley JP, Cohen BJ. Dot blot hybridization assay of B19 virus DNA in clinical specimens. Journal of Clinical Microbiology 27: 459-464, 1989.
9. Musiani M, Zerbini G, Gentilomi G, Rodorigo G, De Rosa V, Gibellini D, Venturoli S, Gallinella G. Persistent B19 Parvovirus Infections in Haemophilic HIV-1 Infected Patients. Journal of Medical Virology 48: 103-108, 1995.
10. Mylonakis E, Dickinson BP, Mileno MD, Flanigan T, Schiffman FJ, Mega A, Rich JD. Persistent parvovirus B19 related anemia of seven years duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy. American Journal of Hematolology 60: 164-166, 1999.
11. Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Soderlund M, Rasnoveanu D, Aiuti F. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies. AIDS 6: 679-684, 2002.
12. Pereira RFA, Paula WNS, Cubel RCN, Nascimento JP Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Memôrias do Instituto Oswaldo Cruz 96: 507-513, 2001.